Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM (AM122) (MALS verified), Unconjugated

Product Overview

• Article Name: Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM (AM122) (MALS verified), Unconjugated
• Biozol Catalog Number: ABS-SPD-M162-100UG
• Supplier Catalog Number: SPD-M162-100ug
• Alternative Catalog Number: ABS-SPD-M162-100UG
• Manufacturer: AcroBiosystems
• Host: Human
• Category: Antikörper
• Species Reactivity: Mouse
• Conjugation: Unconjugated

Product Description

AntiSARSCoV2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM (AM122) is isolated from a SARSCoV2 infected patient and is recombinantly produced from human 293 cells (HEK293). - Antikörper

Product Properties

• Tag: Human IgM | Human Kappa
• Buffer: PBS, pH7.4
• Purity: 0.95
• Form: Powder
• Target: Spike RBD

Images

Immobilized Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM (AM122) (Cat. No. SPD-M162) at 2 µg/mL (100 µL/well) can bind SARS-CoV-2 S protein RBD, His Tag (Cat. No. SPD-C52H1) with a linear range of 0.6-2.4 ng/mL (QC tested).

Serial dilutions of Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM (AM122) (Cat. No. SPD-M162) was detected by Biotinylated Human ACE2, His,Avitag (Cat. No. AC2-H82E6) with a half maximal inhibitory concentration (IC50) of 0.88 µg/mL (Routinely tested).

Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM (AM122) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 0.95.